Language selection

Search

2012-10-17 - Male - 38 Years old

473270

Adverse reaction report number 473270
Latest AER version number 0
Market authorization holder AER number ALL1201204935
Initial received date 2012-10-17
Latest received date 2012-10-17
Age 38 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral10 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral15 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral20 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral25 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral30 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral40 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral50 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral60 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral5 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Incorrect dose administered
Intentional overdose
Off label use
Date modified: